Table 2.

Baseline and End of Treatment (Week 12) Outcomes by Treatment Group

	Baselinea		Week 12
Measure	Health education control	Exercise intervention	Health education control	Exercise intervention	p valueb
PHQ-9 score (depression)	11.6 ± 4.0	11.7 ± 5.4	7.0 ± 5.1	7.4 ± 4.5	.90
Range	3–18	4–22	0–17	3–17
Body mass index	30.0 ± 9.0	31.0 ± 7.0	30.0 ± 9.0	31.0 ± 8.0	.77
Range	19–45	21–42	19–48	21–44
Max VO2 c	25.0 ± 5.0	24.0 ± 5.0	24.0 ± 4.0	29.0 ± 6.0	.002
Range	17–37	13–33	20–32	20–39
Overall physical activityd	11 452 ± 1687	12 133 ± 3581	10 924 ± 2057	11 459 ± 4545	.94
Range	9192–13 016	7784–20 304	8013–15 127	7338–23 664
Sedentary timed  Range	327.2 ± 92.6 202–469	319.6 ± 131.6 146–513	286.6 ± 96.7 154–477	257.4 ± 114.0 92–435	.56

PHQ-9 = Patient Health Questionnaire. For each treatment group n = 15 at baseline and n = 13 at Week 12. Data are reported as mean ± SD.

^a p values at least .05 for all variables when comparing health education and exercise interventions on the baseline assessment using a two sample t test.

^bAnalysis of covariance assessing change in measures. For these analyses, the week 12 assessment was the dependent variable and treatment group and the baseline assessment were the independent variables.

^cVolume of oxygen consumed in milliliters of oxygen per kilogram of body weight per minute.

^dData generated from Modular Signal Recorder accelerometer.